Results 1 to 10 of about 101,444 (326)
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease. [PDF]
Dyslipidemias are often diagnosed based on an individual’s lipid panel that may or may not include Lp(a) or apoB. But these values alone omit key information that can underestimate risk and misdiagnose disease, which leads to imprecise medical therapies ...
Kalwick M, Roth M.
europepmc +2 more sources
Screening for Familial Hypercholesterolemia in Childhood: An Overview of Current Practices Around the World [PDF]
Familial hypercholesterolemia (FH) is a common genetic disorder with a fairly constant worldwide prevalence of 1 case per 311 individuals worldwide.
Maria Elena Capra +5 more
doaj +2 more sources
Triglycerides, Cholesterol, and Depressive Symptoms Among Undergraduate Medical Students: A Cross-Sectional Study [PDF]
Background: Depression is one of the most common mental disorders among undergraduate students, particularly those in medical training, who face high academic demands and emotional burdens.
Maximiliano Olguín-Montiel +9 more
doaj +2 more sources
Fiber in the Treatment of Dyslipidemia in Pediatric Patients [PDF]
Dietary fiber is present in many food categories (fruits, cereals, vegetables, legumes), and is considered a beneficial component of adult and children’s diets.
Maria Elena Capra +5 more
doaj +2 more sources
LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias[S]
We report the design of a targeted resequencing panel for monogenic dyslipidemias, LipidSeq, for the purpose of replacing Sanger sequencing in the clinical detection of dyslipidemia-causing variants.
Christopher T. Johansen +9 more
doaj +2 more sources
Trends in epidemiology of dyslipidemias in India. [PDF]
Sharma S, Gaur K, Gupta R.
europepmc +2 more sources
Bone Health in Patients with Dyslipidemias: An Underestimated Aspect
Beyond being aging-related diseases, atherosclerosis and osteoporosis share common pathogenetic pathways implicated in bone and vascular mineralization. However, the contributory role of dyslipidemia in this interplay is less documented.
P. Anagnostis +4 more
semanticscholar +1 more source
The Evolving Story of Multifactorial Chylomicronemia Syndrome
Multifactorial chylomicronemia syndrome (MCS or type V hyperlipoproteinemia) is the most frequent cause of severe hypertriglyceridemia and is associated with an increased risk of acute pancreatitis, cardiovascular disease, and non-alcoholic ...
Martine Paquette +2 more
doaj +1 more source
Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many reasons of this, including physicians’ inertia,
M. Banach +9 more
semanticscholar +1 more source
Dyslipidemia is a condition characterized by abnormal levels of one or more plasma lipids or lipoproteins. It is a major cause of cardiovascular diseases (CVDs) around the world.
Arti Uniyal, Manish Narang
doaj +1 more source

